12-week home heart rehabilitation program for children with complex congenital heart disease.
Official title: Preliminary Efficacy of a Community-Based Remote Cardiac Rehabilitation Program on Cardiopulmonary Function and Quality of Life in Pediatric Patients With Complex Congenital Heart Disease: A Single Blind, Randomized Controlled Trial
Run by Seoul National University Hospital · NCT07572435 · Data updated 2026-11-12
This program will test whether a 12-week remote cardiac rehabilitation program can improve heart and lung fitness and quality of life in children aged 8–18 with complex congenital heart disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 18 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | May 1, 2026 |
| Main results expected | October 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | May 7, 2026 |
| Trial ID | NCT07572435 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children 8–18 years old with complex congenital heart disease who are at least three months post-surgery, hemodynamically stable, have low physical activity by EVS and KIDSCREEN-27 scores, and can use home remote technology with guardian support.
✕Probably not a fit
Patients with uncontrolled arrhythmias, acute heart failure, myocarditis, pericarditis, those unable to use remote technology, or those already meeting recommended activity levels are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children aged 8 to 18 who are at least three months post-cardiac surgery and have reduced physical activity will be enrolled. Participants are randomly assigned to a 12-week community-based remote cardiac rehabilitation program delivered via mobile apps and video platforms or to standard of care. Outcomes include cardiopulmonary function and quality of life measured before and after the program, with remote monitoring and guardian technical support. The trial tests preliminary efficacy and feasibility of delivering rehabilitation in the home setting for patients with complex congenital heart disease.
Why it matters
Potential benefit: If successful, the program could improve cardiopulmonary fitness and day-to-day wellbeing while making rehabilitation more accessible without frequent hospital visits.
How similar studies have gone: Home- and remotely delivered cardiac rehabilitation has shown benefits in adults and in some small pediatric reports, but robust evidence specifically for remote programs in complex congenital heart disease remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 8 to 18 years. * Diagnosed with complex congenital heart disease (e.g., single ventricle, transposition of the great arteries) and have a history of cardiac surgery. * At least 3 months post-cardiac surgery and maintaining a stable hemodynamic status. * Capable of utilizing remote programs (mobile apps, video platforms, etc.) in the home environment with technical support from guardians. * Participant or guardian has agreed to participate and signed the written informed consent form. * Confirmed to have decreased physical activity level and physical well-being through assessments (Must meet both): * KIDSCREEN-27 Parent Proxy-report 'Physical well-being' domain T-score of 40 or below. * Exercise Vital Sign (EVS) survey indicating moderate-to-vigorous physical activity (MVPA) time of less than 420 minutes per week. Exclusion Criteria: * Ongoing cardiovascular diseases such as uncontrolled arrhythmia, acute heart failure, myocarditis, or pericarditis. * Neurological or musculoskeletal disorders that make independent exercise impossible. * Cognitive impairment that prevents understanding or following the instructions of the remote rehabilitation program. * Clinical levels of depression or anxiety restricting exercise participation, as determined by the attending physician (assessed via Korean Children's Depression Inventory 2: Self-Report \[K-CDI-2:SR\] and Revised Children's Manifest Anxiety Scale, Second Edition \[RCMAS-2\]). * Inability to cooperate with study tests, such as the Cardiopulmonary Exercise Test (CPET), Electrocardiogram (ECG), and 6-Minute Walk Test (6MWT). * Currently wearing an artificial pacemaker.
Where it's running
-
Seoul National University Hospital
Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Sungbae Jo Research Professor, Ph.D
- Email: sungbaejo@snuh.org
- Phone: 82-2-2072-4178
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
-
Optimal timing and treatment strategies for newborn complex congenital heart disease surgery
This project will test whether doing heart surgery within the first week of life versus after day seven leads to fewer deaths and complications for newborns with complex congenital heart defects.
-
Support for parents of children with congenital heart disease during surgery
This study is testing a new support program to see if it can help reduce stress for parents of babies with congenital heart disease during their surgery.
-
Evaluation of a heart valve for patients with pulmonary valve dysfunction
This study tests a new heart valve to see if it can safely help people with problems in their pulmonary valve or right ventricular outflow tract.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.